Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intervention to End Recurrent Unscheduled Bleeding Trial: A Randomized-controlled Trial of Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users

NCT03118297 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03118297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03118297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intervention to End Recurrent Unscheduled Bleeding Trial: A Randomized-controlled Trial of Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Completed
Start date
May 1, 2017
Completion date
January 31, 2018
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, contraception